Перейти к основному содержанию
Tecentriq (Atezolizumab) 1200 mg – Immunotherapy for Cancer  Tecentriq (Atezolizumab) - Macrocare Health Blog

Tecentriq (Atezolizumab) 1200 mg – Immunotherapy for Cancer Tecentriq (Atezolizumab)

Tecentriq (Atezolizumab) is an advanced immunotherapy used to treat several types of cancer. It works by enhancing the immune system’s ability to recognize and attack cancer cells.

 

What is Tecentriq (Atezolizumab)?

Tecentriq is a monoclonal antibody that belongs to the PD-L1 inhibitor class of immunotherapies.

Some cancer cells use the PD-L1 protein to hide from the immune system. Tecentriq works by:

  • Blocking the interaction between PD-L1 and immune cells
  • Enhancing the body's immune response against cancer
  • Helping control tumor growth and spread

In simple terms:
It helps the immune system identify and attack cancer cells.

 

Indications

Tecentriq (Atezolizumab) is used in:

  • Non-Small Cell Lung Cancer (NSCLC)
  • Small Cell Lung Cancer (SCLC)
  • Certain cases of liver cancer
  • Some bladder and urinary tract cancers
  • Other cancers according to treatment protocols

 

Dosage and Administration

  • Standard dose: 1200 mg
  • Administered as an intravenous (IV) infusion
  • Given under specialist medical supervision
  • Treatment schedule varies depending on the prescribed regimen

 

Common Side Effects

May include:

  • Fatigue
  • Nausea
  • Loss of appetite
  • Skin rash
  • Diarrhea
  • Immune-related side effects

Rarely: immune-mediated inflammation affecting the lungs, liver, or endocrine glands may occur and require close monitoring.

 

Monitoring During Treatment

Patients on Tecentriq (Atezolizumab) require:

  • Assessment of tumor response
  • Liver and kidney function monitoring
  • Immune system evaluation
  • Overall health assessment

 

Availability & How to Access Treatment

Tecentriq (Atezolizumab) is available through Macrocare’s approved partners.

You can now request and access the medication easily through us.

WhatsApp contact for medication requests:
Click here

 

Tecentriq (Atezolizumab) Tecentriq (Atezolizumab) 1200 mg is an advanced immunotherapy that helps the immune system recognize and attack cancer cells, improving disease control across multiple cancer types.

 

Medical Disclaimer:
This content is for educational purposes only and does not replace professional medical advice. Treatment decisions should always be made by a qualified physician.

 

Другие статьи

Введите номер мобильного телефона

Пожалуйста, укажите ваш номер телефона, чтобы мы могли связаться с вами и узнать о вашей проблеме со здоровьем.

Конфиденциальность защищена: ваша медицинская и личная информация хранится полностью конфиденциально и защищена с использованием отраслевых стандартов защиты.

СВЯЗАТЬСЯ С НАМИ

Свяжитесь с нами

Пожалуйста, укажите ваш номер телефона, чтобы мы могли связаться с вами и узнать о вашей проблеме со здоровьем.